Jury orders Takeda subsidiary to pay Bayer $155 million

A US jury has ordered pharmaceutical company Baxalta Inc. to pay $155 million to Bayer Healthcare following a patent infringement trial.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Bayer takes pre-emptive strike to protect haemophilia treatment

31 August 2017 Bayer HealthCare has filed a lawsuit against Nektar Therapeutics and Baxalta seeking a declaration that a treatment for haemophilia A does not infringe their patent.

Big Pharma

AG weighs in on Bayer patent case

11 April 2019 An advocate general has advised the Court of Justice of the European Union on damages in a case between Bayer and pharmaceutical companies Richter and Exeltis.

Big Pharma

Takeda subsidiary ordered to pay Bayer $182m after overturn bid fails

27 August 2019 A Takeda subsidiary cannot overturn a $155 million jury verdict that it infringed one of Bayer’s patents, a district court has ruled.

More on this story

Americas

Bayer takes pre-emptive strike to protect haemophilia treatment

31 August 2017 Bayer HealthCare has filed a lawsuit against Nektar Therapeutics and Baxalta seeking a declaration that a treatment for haemophilia A does not infringe their patent.

Big Pharma

AG weighs in on Bayer patent case

11 April 2019 An advocate general has advised the Court of Justice of the European Union on damages in a case between Bayer and pharmaceutical companies Richter and Exeltis.

Big Pharma

Takeda subsidiary ordered to pay Bayer $182m after overturn bid fails

27 August 2019 A Takeda subsidiary cannot overturn a $155 million jury verdict that it infringed one of Bayer’s patents, a district court has ruled.

More on this story

Americas

Bayer takes pre-emptive strike to protect haemophilia treatment

31 August 2017 Bayer HealthCare has filed a lawsuit against Nektar Therapeutics and Baxalta seeking a declaration that a treatment for haemophilia A does not infringe their patent.

Big Pharma

AG weighs in on Bayer patent case

11 April 2019 An advocate general has advised the Court of Justice of the European Union on damages in a case between Bayer and pharmaceutical companies Richter and Exeltis.

Big Pharma

Takeda subsidiary ordered to pay Bayer $182m after overturn bid fails

27 August 2019 A Takeda subsidiary cannot overturn a $155 million jury verdict that it infringed one of Bayer’s patents, a district court has ruled.